We investigated whether patients with IPF are more susceptible to SARS-CoV-2 infection and whether subsequent virus-induced interferons and cytokines affected levels of ACE2 and TMPRSS2. This evidence concerns the gene ACE2 and idiopathic pulmonary fibrosis.